Synovis Life Technologies, Inc. (NASDAQ:SYNO)
A diversified medical device company; develops, manufactures and markets products for the surgical and interventional treatment of disease. Business is conducted in two reportable segments, the surgical business and the interventional business.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Red Raider is Lord
Recs
SYNO to purchase Span-America Medical Systems, SPAN, ? Would
be a boon for both Co.s? M & A leads to growing co.s, market expansion.
Recs
SYNO or Synovis Life Technologies, Inc.had a fourth quarter profit that helped this stock to rise and rise high! Their board of directors has also approved a buyback of One-Million stocks. Syno has at the current time about 12.4Million in outstanding stock. Part of this buy-back will be done on the open market and also through private sectors. Get this stock before it rises anymore. Personally, I'd rather have the "rise" in my bank account. How about You?
Recs
Member of the "Mini-Cap Monsters."
Recs
great growth potential
Recs
Their product "Veritas", for challenging abdominal wall and breast reconstruction
Recs
Increase on 3 times normal volume to start right side of possible base. IBD
Recs
They have a prduct line that is the best in their market.
Recs
SYNO has a solid balance sheet, important patents in microvascular devices, and no doebt. They can go to the markets for product launch/marketing cash when needed (end of 2007).
SYNO needs to lower SG&A expense and invest the savings in R&D.
They are a disruptor in microsurgical technology, and will either grow fast or be acquired.
Two year price target is $28-$30.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 9 of 9